6 results
·
23ms
·
Sources: EU EUDAMED, US FDA
Filters
Classification: FDA Class 2
×
Adaptive Biotechnologies clonoSEQ Assay
FDA 510(k)
FDA Class 2
·Pathology
Dna-Based Test For Minimal Residual Disease For Hematologic Malignancies
FDA classification
FDA Class 2
·Dna-Based Test For Minimal Residual Disease For Hematologic Malignancies
VENTANA anti-MLH-1(M1) Mouse Monoclonal Primary Antibody, VENTANA anti-PMS2 (A16-4) Mouse Monoclonal Primary Antibody, VENTANA anti-MSH2 (G219-1129) Mouse Monoclonal Primary Antibody, VENTANA anti-MSH6 (SP 93) Mouse Monoclonal Primary Antibody, VENTANA anti-BRAF V600E (VE1) Mouse Monoclonal Primary Antibody
FDA 510(k)
FDA Class 2
·Immunology
LZI Carisoprodol Metabolite (Meprobamate) Enzyme Immunoassay
FDA 510(k)
FDA Class 2
·Clinical Toxicology
Meprobamate Test System
FDA classification
FDA Class 2
·Meprobamate Test System
Lynch Syndrome Test System
FDA classification
FDA Class 2
·Lynch Syndrome Test System